Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost in Menière's Disease
NCT01973114Phase 2Unknown
- Sponsor
- Synphora AB
- Start
- Oct 2013
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprost in Ménière's disease, sponsored by Synphora AB. Status: unknown.
02
Drugs
latanoprost
03
Conditions
Ménière's disease
Beyond the preview
Go deeper on NCT01973114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01973114.